Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net loss from operations	$ (97,503,000)	$ (69,662,000)
Adjustments to reconcile net loss from operations to net cash used by operating activities:
Depreciation and amortization	5,206,000	12,925,000
Stock based compensation		4,000
Gain/(loss) on equity method investment	34,000	(129,000)
Loss on investments	33,506,000	13,386,000
Change in ROU assets	1,009,000	(7,721,000)
Gain on extinguishment of debt		(110,000)
Deferred tax loss		38,000
Loss on sales of assets	1,300,000
Impairment of fixed assets		2,843,000
Impairment of intangible assets	7,418,000
Impairment of real estate	812,000
Impairment of Goodwill	30,978,000
Impairment of accounts receivable	3,023,000
Impairment of notes receivable	3,794,000	1,525,000
Impairment of other investments		5,637,000
Decrease (increase) in assets:
Accounts receivable	1,316,000	(1,891,000)
Inventory	5,483,000	540,000
Prepaid expenses and other current assets	996,000	1,766,000
Other assets	2,392,000	(2,210,000)
Increase (decrease) in liabilities:
Accounts payable	(2,260,000)	3,994,000
Accrued expenses	(15,646,000)	4,307,000
Change in ROU liabilities	(1,013,000)
Other liabilities	(39,000)	(298,000)
Net cash used by operating activities	(19,194,000)	(26,953,000)
Cash flows from investing activities:
Purchase of property, plant and equipment	(818,000)	(2,294,000)
Purchase of real estate		(732,000)
Purchase of investment		(195,000)
Purchase of marketable securities		(14,884,000)
Disposal of property, plant & equipment	248,000	2,152,000
Asset acquired with APB acquisition		(1,879,000)
Asset acquired with Sentinel acquisition	40,000
Conversion of SHRG to consolidation		3,038,000
Change in Equity investment		(113,000)
Issuance of new notes receivable, net origination fees	(1,046,000)	(3,621,000)
Payment received on notes receivable	1,010,000	1,067,000
Sale of marketable securities	9,502,000
Purchase of intangible assets		(508,000)
Net cash provided (used) by investing activities	8,936,000	(17,969,000)
Cash flows from financing activities:
Payments of long-term debt	(4,246,000)	(3,504,000)
Borrowings of long-term debt	1,829,000	9,602,000
Issuances of common stock, net of issuance costs		1,519,000
Net cash (used) provided by financing activities	(2,417,000)	7,617,000
Net decrease in cash	(12,675,000)	(37,305,000)
Cash and cash equivalents at beginning of year	19,290,000	56,595,000
Cash and cash equivalents at end of year	$ 6,615,000	$ 19,290,000